139 related articles for article (PubMed ID: 26496240)
1. Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.
Ciniselli CM; De Bortoli M; Taverna E; Varinelli L; Pizzamiglio S; Veneroni S; Bonini C; Orlandi R; Verderio P; Bongarzone I
Expert Rev Proteomics; 2015; 12(6):695-701. PubMed ID: 26496240
[TBL] [Abstract][Full Text] [Related]
2. Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
Bahr TM; Ward DM; Jia X; Ohls RK; German KR; Christensen RD
Blood Cells Mol Dis; 2021 May; 88():102536. PubMed ID: 33450539
[TBL] [Abstract][Full Text] [Related]
3. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
[TBL] [Abstract][Full Text] [Related]
4. Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.
Cavallaro F; Duca L; Pisani LF; Rigolini R; Spina L; Tontini GE; Munizio N; Costa E; Cappellini MD; Vecchi M; Pastorelli L
Can J Gastroenterol Hepatol; 2017; 2017():6843976. PubMed ID: 28191453
[No Abstract] [Full Text] [Related]
5. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
Hara M; Nakamura Y; Suzuki H; Asao R; Nakamura M; Nishida K; Kenmotsu S; Inagaki M; Tsuji M; Kiuchi Y; Ohsawa I; Goto Y; Gotoh H
Nephrology (Carlton); 2019 Aug; 24(8):819-826. PubMed ID: 30239062
[TBL] [Abstract][Full Text] [Related]
7. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
[TBL] [Abstract][Full Text] [Related]
8. Immunoassay for human serum erythroferrone.
Ganz T; Jung G; Naeim A; Ginzburg Y; Pakbaz Z; Walter PB; Kautz L; Nemeth E
Blood; 2017 Sep; 130(10):1243-1246. PubMed ID: 28739636
[TBL] [Abstract][Full Text] [Related]
9. EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.
Schotten N; Laarakkers CM; Roelofs RW; Origa R; van Kraaij MG; Swinkels DW
Am J Hematol; 2017 Mar; 92(3):E29-E31. PubMed ID: 28033686
[No Abstract] [Full Text] [Related]
10. The Clinical Value of Hepcidin in Breast Cancer and Its Bone Metastasis.
Shao X; Cao F; Tao M
Ann Clin Lab Sci; 2017 Mar; 47(2):120-128. PubMed ID: 28442512
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin as a potential biomarker for blood doping.
Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
[TBL] [Abstract][Full Text] [Related]
12. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
El-Gamal RAE; Abdel-Messih IY; Habashy DM; Zaiema SEG; Pessar SA
Ann Hematol; 2020 Jan; 99(1):31-39. PubMed ID: 31834456
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
14. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
Mangaonkar AA; Thawer F; Son J; Ajebo G; Xu H; Barrett NJ; Wells LG; Bowman L; Clair B; Patel N; Bora P; Jung G; Nemeth E; Kutlar A
Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737
[TBL] [Abstract][Full Text] [Related]
15. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.
Matsumoto M; Tsujino T; Lee-Kawabata M; Naito Y; Akahori H; Sakoda T; Ohyanagi M; Tomosugi N; Masuyama T
Circ J; 2010 Feb; 74(2):301-6. PubMed ID: 20019408
[TBL] [Abstract][Full Text] [Related]
16. Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.
Tisi MC; Bozzoli V; Giachelia M; Massini G; Ricerca BM; Maiolo E; D'Alo' F; Larocca LM; Piciocchi A; Tjalsma H; Swinkels DW; Voso MT; Leone G; Hohaus S
Leuk Lymphoma; 2014 Feb; 55(2):270-5. PubMed ID: 23647063
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietic regulators of iron metabolism.
Ganz T
Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
[TBL] [Abstract][Full Text] [Related]
18. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
20. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
